| Literature DB >> 19188255 |
Claudia Sissi1, Manlio Palumbo.
Abstract
The catalytic steps through which DNA topoisomerases produce their biological effects and the interference of drug molecules with the enzyme-DNA cleavage complex have been thoroughly investigated both from the biophysical and the biochemical point of view. This provides the basic structural insight on how this family of essential enzymes works in living systems and how their functions can be impaired by natural and synthetic compounds. Besides other factors, the physiological environment is known to affect substantially the biological properties of topoisomerases, a key role being played by metal ion cofactors, especially divalent ions (Mg(2+)), that are crucial to bestow and modulate catalytic activity by exploiting distinctive chemical features such as ionic size, hardness and characteristics of the coordination sphere including coordination number and geometry. Indeed, metal ions mediate fundamental aspects of the topoisomerase-driven transphosphorylation process by affecting the kinetics of the forward and the reverse steps and by modifying the enzyme conformation and flexibility. Of particular interest in type IA and type II enzymes are ionic interactions involving the Toprim fold, a protein domain conserved through evolution that contains a number of acidic residues essential for catalysis. A general two-metal ion mechanism is widely accepted to account for the biophysical and biochemical data thus far available.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19188255 PMCID: PMC2647314 DOI: 10.1093/nar/gkp024
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Principal biochemical features of the DNA topoisomerases
| Type | Subfamily | Name | Organism(s) | ATP required | Mg required | Linkage to tyrosine | Mechanism | Toprim |
|---|---|---|---|---|---|---|---|---|
| I | IA | Topo I | Eubacteria, archaea, plants | / | + | 5′ | Strand passage | Yes |
| Topo III | Eubacteria, archaea, eukaryotes | / | + | 5′ | Strand passage | Yes | ||
| Reverse gyrase | Eubacteria, archaea | + | + | 5′ | Strand passage | Yes | ||
| IB | Topo I | Eukaryotes, viruses, plants | / | / | 3′ | Controlled rotation | No | |
| IC | Topo V | Archaea | / | / | 3′ | Controlled rotation | No | |
| II | IIA | Topo II | Eukaryotes | + | + | 5′ | Strand passage | Yes |
| Gyrase | Eubacteria, archaea, plants | + | + | 5′ | Strand passage | Yes | ||
| Topo IV | Eubacteria | + | + | 5′ | Strand passage | Yes | ||
| IIB | Topo VI | Archaea, plants | + | + | 5′ | Strand passage | Yes |
Figure 1.Roles of Mg2+ in topoisomerase-mediated transphosphorylation catalysis: (A) activation of attacking nucleophile (outer sphere); (B) stabilization of tyrosinate; (C) stabilization of transition state; and (D) stabilization of leaving group.
Figure 2.Structural organization of the Toprim domain in the topoisomerase family. (A) Schematic representation of the location of the conserved aspartate and glutamate residues with blue arrows representing tracts of β-barrel secondary structures and red cylinders helical arrangements. (B) Three-dimensional structures of the DxDxD and E catalytic Toprim residues coordinated to a Mg2+ ion in S. cerevisiae topoisomerase II bound to DNA (obtained from the PDB ID 2RGR).
Sequence alignment of the catalytically relevant residues in Toprim-containing topoisomerases
| Type IA | Glu | Asp Asp Glu | Tyr | Chain length | ||
| Topo I ( | 9 | 111 113 115 | 319 | 865 | ||
| Topo I ( | 9 | 117 119 121 | 325 | 871 | ||
| Topo III ( | 7 | 103 105 107 | 328 | 653 | ||
| Reverse gyrase ( | 512 | 631 633 635 | 809 | 1054 | ||
| Type IIA | Glu | Asp Asp Asp | Tyr | Chain length | ||
| TopoII (Human α) | 454 | 541 543 545 | 805 | 1531 | ||
| TopoII (Human β) | 477 | 557 559 561 | 826 | 1626 | ||
| TopoII ( | 450 | 527 529 531 | 782 | 1428 | ||
| Gyrase ( | GyrB | 424 | 498 500 502 | GyrA | 122 | 804 + 875 |
| TopoIV ( | ParE | 418 | 490 492 494 | ParC | 120 | 630 + 752 |
| Type IIB | Tyr | Glu Asp Asp | Chain length | |||
| TopoVI ( | Subunit A | 106 | 209 261 263 | 389 |
aGyrase, topoisomerase IVand topoisomerase VI consist of two subunits.